Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXY9NF
|
||||
| Drug Name |
N-{(S)-1-[2-(4-Methoxy-phenylamino)-ethylcarbamoyl]-3,3-dimethyl-butyl}-3-methyl-benzamide
|
||||
| Synonyms |
CHEMBL198612
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H33N3O3
|
||||
| Canonical SMILES |
COc1ccc(NCCNC(=O)[C@H](CC(C)(C)C)NC(=O)c2cccc(C)c2)cc1
|
||||
| InChI |
InChI=1S/C24H33N3O3/c1-17-7-6-8-18(15-17)22(28)27-21(16-24(2,3)4)23(29)26-14-13-25-19-9-11-20(30-5)12-10-19/h6-12,15,21,25H,13-14,16H2,1-5H3,(H,26,29)(H,27,28)/t21-/m0/s1
|
||||
| InChIKey |
DRKSBIJCXVSMBY-NRFANRHFSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.